USD 16.91
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | 8.96 Billion | 7.96 Billion | 9.34 Billion | 8.75 Billion | 6.83 Billion | 6.18 Billion |
Cost of Revenue | 6.02 Billion | 5.85 Billion | 1.6 Billion | 1.61 Billion | 1.11 Billion | 995.28 Million |
Gross Profit | 2.94 Billion | 2.11 Billion | 7.73 Billion | 7.13 Billion | 5.71 Billion | 5.18 Billion |
Operating Expenses | 249.79 Million | 1.29 Billion | 5.57 Billion | 5.21 Billion | 4.9 Billion | 4.38 Billion |
Selling, General and Administrative Expenses | 249.79 Million | 1.29 Billion | 3.88 Billion | 3.6 Billion | 3.4 Billion | 3.35 Billion |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 5.32 Million | 17.91 Million | -1.32 Million | 43.31 Million | 101.8 Million |
Cost and Expenses | 6.27 Billion | 7.14 Billion | 7.18 Billion | 6.83 Billion | 6.01 Billion | 5.37 Billion |
Operating Income | 2.69 Billion | 820.32 Million | 2.15 Billion | 1.92 Billion | 811.91 Million | 808.32 Million |
Interest Expense | 151.34 Million | 87.02 Million | 79.81 Million | 92.51 Million | 112.85 Million | 86.06 Million |
Income Tax Expense | 186.84 Million | 223.25 Million | 561.73 Million | 480.93 Million | 157.16 Million | 163.18 Million |
Earnings before Tax | 730.65 Million | 931.18 Million | 2.07 Billion | 1.82 Billion | 699.06 Million | 722.25 Million |
Net Income | 511.09 Million | 684.98 Million | 1.46 Billion | 1.31 Billion | 527.74 Million | 549.72 Million |
Earnings Per Share Basic | 1.07 | 1.46 | 3.05 | 2.75 | 1.11 | 1.22 |
Earnings Per Share Diluted | 1.07 | 1.45 | 3.02 | 2.73 | 1.11 | 1.22 |
Weighted Average Shares Outstanding | 476.1 Million | 469.76 Million | 478.14 Million | 477.37 Million | 474.82 Million | 448.78 Million |
Weighted Average Shares Outstanding (Diluted) | 476.98 Million | 472.44 Million | 482.88 Million | 481.46 Million | 477.16 Million | 450.3 Million |
Gross Margin | 0.33 | 0.27 | 0.83 | 0.82 | 0.84 | 0.84 |
EBIT Margin | 0.19 | 0.19 | 0.30 | 0.29 | 0.21 | 0.17 |
Profit Margin | 0.06 | 0.09 | 0.16 | 0.15 | 0.08 | 0.09 |
EBITDA | 1.65 Billion | 1.28 Billion | 2.83 Billion | 2.15 Billion | 1.04 Billion | 1.08 Billion |
Earnings Before Tax Margin | 0.30 | 0.10 | 0.23 | 0.22 | 0.12 | 0.13 |
Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
---|---|---|---|---|---|---|
Revenue | 4.38 Billion | 8.66 Billion | 2.33 Billion | 4.27 Billion | 2.15 Billion | 7.96 Billion |
Cost of Revenue | 3.39 Billion | 6.6 Billion | 1.55 Billion | 3.2 Billion | 1.45 Billion | 5.85 Billion |
Gross Profit | 987.4 Million | 2.05 Billion | 778.08 Million | 1.06 Billion | 694.17 Million | 2.11 Billion |
Operating Expenses | 778.06 Million | 1.48 Billion | 63.63 Million | 735.71 Million | 511.44 Million | 1.29 Billion |
Selling, General and Administrative Expenses | 778.06 Million | - | 63.63 Million | 735.71 Million | 61.26 Million | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 32.34 Million | - | - | - | 5.32 Million |
Cost and Expenses | 4.17 Billion | 8.08 Billion | 1.61 Billion | 3.94 Billion | 1.97 Billion | 7.14 Billion |
Operating Income | 209.34 Million | 575.19 Million | 714.45 Million | 333.5 Million | 182.72 Million | 820.32 Million |
Interest Expense | 85.93 Million | 151.34 Million | - | 65.41 Million | - | 87.02 Million |
Income Tax Expense | 104.93 Million | 186.84 Million | 52.46 Million | 81.91 Million | 40.95 Million | 223.25 Million |
Earnings before Tax | 430.6 Million | 730.65 Million | 215.3 Million | 300.04 Million | 150.02 Million | 931.18 Million |
Net Income | 308.78 Million | 511.09 Million | 154.39 Million | 202.31 Million | 101.15 Million | 684.98 Million |
Earnings Per Share Basic | 0.65 | - | 0.32 | 0.43 | 0.21 | - |
Earnings Per Share Diluted | 0.65 | - | 0.32 | 0.43 | 0.21 | - |
Weighted Average Shares Outstanding | 476.1 Million | 476.1 Million | 478.77 Million | 473.43 Million | 474.9 Million | 469.76 Million |
Weighted Average Shares Outstanding (Diluted) | 476.98 Million | 476.98 Million | 479.26 Million | 474.71 Million | 474.71 Million | 472.44 Million |
Gross Margin | 0.23 | 0.24 | 0.33 | 0.25 | 0.32 | 0.27 |
EBIT Margin | 0.14 | - | 0.19 | 0.17 | 0.17 | - |
Profit Margin | 0.07 | 0.06 | 0.07 | 0.05 | 0.05 | 0.09 |
EBITDA | 602.98 Million | - | 446.06 Million | 717.17 Million | 374.56 Million | - |
Earnings Before Tax Margin | 0.05 | 0.07 | 0.31 | 0.08 | 0.08 | 0.10 |
CDGLY
MDTR
RITM-PA
600703
8960
ORCHPHARMA